期刊文献+

复方玄驹胶囊对类风湿关节炎患者Th17细胞/白介素17的影响 被引量:5

The effect of Th17 cell percentage/Interleukin-17 in patients with rheumatoid arthritis after compound Xuanju Capsule therapy
原文传递
导出
摘要 目的:研究复方玄驹胶囊对类风湿关节炎患者外周血Th17细胞的比例及白介素17(IL-17)水平的影响。方法:选择类风湿关节炎患者30例和健康对照30例,类风湿关节炎患者接受复方玄驹胶囊治疗2个月。采用流式细胞仪检测外周血CD4+T淋巴细胞中Th17细胞的比例,ELISA法检测外周血中IL-17的表达水平。结果:治疗前,类风湿关节炎患者Th17细胞亚群的比例为(1.84±0.79)%,显著高于健康对照组(0.62±0.31)%。类风湿关节炎患者血清IL-17水平为387.46±82.21pg/ml,显著高于健康对照组45.36±19.31 pg/ml。复方玄驹治疗1月和2月后,类风湿关节炎患者外周血CD4+细胞中Th17细胞亚群的比例分别为为(1.93±0.58)%和(1.53±0.72)%,与治疗前相比无统计学差异。血清IL-17水平分别为为288.21±49.06pg/ml和122.47±51.26pg/ml,差异有统计学意义。复方玄驹治疗2月后,类风湿关节炎患者临床症状及炎症指标较治疗前改善,差异有统计学意义。结论:Th17细胞及其分泌的IL-17可能在类风湿关节炎的发病中起作用。复方玄驹胶囊能抑制Th17细胞分泌IL-17,但不能降低Th17细胞的比例。 Objective: To explore the effect of compound Xuanju Capsule therapy on circulating Thl7 cell percentage and serum interleukin 17 (IL-17) level in patient with rheumatoid arthritis (RA). Methods : 30 patients with RA , who received 2 months compound xuanju capsule therapy , and 30 healthy controls were recruited. The percentage of circulating Th17 cells were determined by fiowcytometry, and serum concentration of IL-17 were determined by ELISA. Results: The percentage of Th17 cells were significantly higher in RA patients( 1.84 ±0.79)% compared with health controls (0.62 ± 0.31 ) % ( P 〈 0.05 ). Serum IL-17 level in RA patients ( 387.46 ±82.21 pg/ml) were obviously higher than those in healthy controls(45.36±19.31pg/ml) ( P 〈 0.05 ). After compound xuanju capsule therapy, no signifieandy differences were found in the percentage of Th17 cells [ 1 month ( 1.93 ± 0.58 ) % and 2 month( 1.53 ± 0.72 ) % ]. In contrast, serum IL-17 level was signifi- cantly decreased [ 1 month ( 288.21 ± 49.06pg/rnl) and 2 month ( 122.47 ± 51.26pg/ml) ] ( P 〈 0.05 ). After 2 months therapy, the clinical response and erythrocyte sedimentation rate (ESR) , C-reactive protein(CRP) was significantly improvement than before (P 〈 0.05 ). Conclusion: Thl7 cells and IL-17 might play an important role in the pathogenesis of RA. Compound xuanju capsule cannot decrease the frequencies but can inhibit the function of Th17 cells.
出处 《中药药理与临床》 CAS CSCD 北大核心 2016年第6期198-201,共4页 Pharmacology and Clinics of Chinese Materia Medica
基金 兰州大学第二医院院内中医药项目YJzy201324
关键词 复方玄驹胶囊 类风湿关节炎 TH17细胞 白细胞介素17 compound Xuanju Capsule (复方玄驹胶囊) rheumatoid arthritis Thl7 cell Intedeukin 17
  • 相关文献

参考文献6

二级参考文献49

  • 1陈颖娟,高洁生,吴轰,李芬,田静,谢希.不同DMARDs联合用药治疗类风湿关节炎疗效与安全性的研究[J].中国现代医学杂志,2005,15(4):576-581. 被引量:18
  • 2祁艳萍,赵伟.来氟米特联合甲氨蝶呤治疗类风湿关节炎的临床疗效[J].中国医药导报,2007,4(06Z):51-52. 被引量:13
  • 3Sato K,Suematsu A,Okamoto K,et al.Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction.J Exp Med,2006,203:2673-2682.
  • 4Zheng SG,Wang J,Horwitz DA.Cutting edge:Fexp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-{beta} are resistant to Th17 conversion by IL-6.J Immunol,2008,180:7112-7116.
  • 5Cua DJ,Kastelein RA.TGF-beta,a double agent in the immune pathology war.Nat Immunol,2006,7:557-559.
  • 6Batten M,Li J,Yi S,et al.Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.Nat Immunol,2006,7:929-936.
  • 7Nistala K,Moncrieffe H,Newton KR,et al.lnterleukin-17-producing T cells are enriched in the joints of children with arthritis,but have a reciprocal relationship to regulatory T cell numbers.Arthritis Rheum,2008,58:875-887.
  • 8Shahrara S,Huang Q,Mandelin AM,et al.TH-17 cells in rheumatoid arthritis.Arthritis Res Ther,2008,10:R93.
  • 9Hirota K,Yoshitomi H,Hashimoto M,et al.Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model.J Exp Med,2007,204:2803-2812.
  • 10Zhang C,Zhang J,Yang B,et al.Cyclosporin A inhibits the production of IL-17 by memory Thl7 cells from healthy individuals and patients with rheumatoid arthritis.Cytokine,2008,42:345-352.

共引文献2075

同被引文献62

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部